Following completion of the ongoing Phase 2a proof-of-pharmacology study with BMB-101, Bright Minds plans to select and ...
An update from Bright Minds Biosciences ( ($TSE:DRUG) ) is now available. Bright Minds Biosciences has announced the initiation of its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback